The burden of pediatric invasive meningococcal disease in Spain (2008-2013)

Pediatric Infectious Disease Journal

Volumn 35, Issue 4, 2016, Pages 407-413

  Rivero Calle, I ^c   Vilanova Trillo, L ^c   Pardo Seco, Jacobo ^b   Salvado, Lidia Blanco ^a   Quinteiro, Laura Illade ^a   Martinon Torres, F ^c   Palacios, A ^c   Prieto, L M ^c   Grasa, C D ^c   Llorente, M ^c   Perez, B ^c   Tagarro, A ^c   Orio M ^c   Baquero Artigao, F ^c   Bueno, M ^c   Saavedra Lozano, J ^c   CalvoRey, C ^c   Pineiro R ^c   Mate I ^c   Jensen, J M ^c   Bello, P ^c   Aleo, E ^c   Blumenfeld, J ^c   Badillo, K ^c   Fernandez Cooke E ^c   La Orden, F ^c   Perez, R ^c   Navas, A ^c   Feito, C ^c   Otheo, E ^c   Jimenez, A ^c   Alvarez, C ^c   Monge, C Calvo ^c   Concha Torre, A ^c   Bernaola, E ^c   Martinez, M C ^c   Gimenez, F ^c   Fuentes, A ^c   Garcia E ^c   Paredes, C ^c   Reyes, S ^c   Blanco, L ^c   Illade, L ^c   Rojo, P ^c   Alvarez, A ^c   Galan, P ^c   Martinez, J ^c   Villalobos, E ^c   Escosa, L ^c   Gomez, R ^c   Moran, L ^c   Navarro, M ^c   Santos, M M ^c   Aguado, I ^c   Cilleruelo, M J ^c   Perez Jorge M C ^c   Roa, M A ^c   Restan, T ^c   Perez Caballero C ^c   Cerdeira, N ^c   Sancho, R ^c   Benito, S ^c   Onate E ^c   Vivanco, A ^c   Fernandez, R ^c   Moreno, L ^c   De La Cruz, J ^c   Santiago, C ^c   Millan, M L ^c   Leon, M C ^c   Navarro, A ^c   more..

^a Instituto de Salud Carlos III   (Spain)

^b Santiago University Clinical Hospital   (Spain)

^c NONE

Author keywords

Burden; Meningococcal disease; Neisseria meningitidis

Indexed keywords

ADRENALIN; CEFOTAXIME; CEFTRIAXONE; DOBUTAMINE; DOPAMINE; MENINGOCOCCUS VACCINE; MEROPENEM; MILRINONE; NORADRENALIN; PHENYLEPHRINE; TERLIPRESSIN; VANCOMYCIN;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTHROPATHY; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BACTERIAL ENDOCARDITIS; BACTERIAL SUPERINFECTION; CHILD; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; COHORT ANALYSIS; DISEASE COURSE; ENCEPHALITIS; EPIDEMIC MENINGITIS; FEMALE; GLASGOW COMA SCALE; HOSPITAL DISCHARGE; HUMAN; INFANT; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MENINGOCOCCEMIA; MENINGOCOCCOSIS; MORBIDITY; MYOCARDITIS; NEISSERIA MENINGITIDIS; OPTIC NEURITIS; POSITIVE END EXPIRATORY PRESSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SEPSIS; SEPTICEMIA; SPAIN; THROMBOCYTOPENIA; CLINICAL TRIAL; COST OF ILLNESS; HEALTH SURVEY; HISTORY; MENINGOCOCCAL INFECTIONS; MULTICENTER STUDY; NEWBORN; OUTCOME ASSESSMENT; RISK FACTOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COST OF ILLNESS; FEMALE; HISTORY, 21ST CENTURY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; PATIENT OUTCOME ASSESSMENT; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 84961878096     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000001048     Document Type: Review

References (27)

1. Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec. 2011;86:521-39.
2. Edmond K, Clark A, Korczak VS, et al. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:317-328.
3. Rivero Calle I, Rodriguez-Tenreiro Sánchez C, Martinón-Torres F. [Meningococcal vaccines. Global epidemiological situation and strategies for prevention by vaccination]. Enferm Infecc Microbiol Clin. 2015;33:257-267.
4. Khatami A, Pollard AJ. The epidemiology of meningococcal disease and the impact of vaccines. Expert Rev Vaccines. 2010;9:285-298.
5. Panatto D, Amicizia D, Lai PL, et al. Neisseria meningitidis B vaccines. Expert Rev Vaccines. 2011;10:1337-1351.
6. de Vigilancia Epidemiológica S. Centro Nacional de Epidemiología. Instituto Carlos III. Comentario epidemiológico de las enfermedades de declaración obligatoria y sistema de información microbiológica. España. Año 2010. Bol Epidemiol Sem, 2011;19:100-116.
7. Vyse A, Anonychuk A, Jäkel A, et al. The burden and impact of severe and long-term sequelae of meningococcal disease. Expert Rev Anti Infect Ther. 2013;11:597-604.
8. Cohn AC, Harrison LH. Meningococcal vaccines: current issues and future strategies. Drugs. 2013;73:1147-1155.
9. Montero-Martín M, Inwald DP, Carrol ED, et al. Prognostic markers of meningococcal disease in children: recent advances and future challenges. Expert Rev Anti Infect Ther. 2014;12:1357-1369.
10. Martinón-Torres F, Czajka H, Center KJ, et al. 13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants. Pediatrics. 2015;135:e876-e886.
11. Rosenstein NE, Perkins BA, Stephens DS, et al. Meningococcal disease. N Engl J Med. 2001;344:1378-1388.
12. Viner RM, Booy R, Johnson H, et al. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study. Lancet Neurol. 2012;11:774-783.
13. Sumpter R, Brunklaus A, McWilliam R, et al. Health-related quality-of-life and behavioural outcome in survivors of childhood meningitis. Brain Inj. 2011;25:1288-1295.
14. Christie D, Viner RM, Knox K, et al. Long-term outcomes of pneumococcal meningitis in childhood and adolescence. Eur J Pediatr. 2011;170:997-1006.
15. Borg J, Christie D, Coen PG, et al. Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study. Pediatrics. 2009;123:e502-e509.
16. ECDC Surveillance Atlas of Infectious Diseases. Available at: http://ecdc. europa.eu/en/data-tools/atlas/Pages/atlas.aspx#sthash.bt62fIGp.dpuf. Accessed September 11, 2015.
17. Fiser DH, Long N, Roberson PK, et al. Relationship of pediatric overall performance category and pediatric cerebral performance category scores at pediatric intensive care unit discharge with outcome measures collected at hospital discharge and 1-and 6-month follow-up assessments. Crit Care Med. 2000;28:2616-2620.
18. Fiser DH, Tilford JM, Roberson PK. Relationship of illness severity and length of stay to functional outcomes in the pediatric intensive care unit: a multi-institutional study. Crit Care Med. 2000;28:1173-1179.
19. Dastouri F, Hosseini AM, Haworth E, et al. Complications of serogroup B meningococcal disease in survivors: a review. Infect Disord Drug Targets. 2014;14:205-212.
20. Buysse CM, Oranje AP, Zuidema E, et al. Long-term skin scarring and orthopaedic sequelae in survivors of meningococcal septic shock. Arch Dis Child. 2009;94:381-386.
21. Bache CE, Torode IP. Orthopaedic sequelae of meningococcal septicemia. J Pediatr Orthop. 2006;26:135-139.
22. Bettinger JA, Scheifele DW, Le Saux N, et al; Members of Canadian Immunization Monitoring Program, Active (IMPACT). The disease burden of invasive meningococcal serogroup B disease in Canada. Pediatr Infect Dis J. 2013;32:e20-e25.
23. Erickson L, De Wals P. Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994. Clin Infect Dis. 1998;26:1159-1164.
24. Schildkamp RL, Lodder MC, Bijlmer HA, et al. Clinical manifestations and course of meningococcal disease in 562 patients. Scand J Infect Dis. 1996;28:47-51.
25. Trotter CL, Maiden MC. Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines. 2009;8:851-861.
26. European Centre for Disease Prevention and Control. Annual Epidemiological Report 2014-Vaccine-Preventable Diseases-Invasive Bacterial Diseases. Stockholm: ECDC; 2015.
27. World Health Organization. Immunization, Vaccines and Biologicals. Meningococcal meningitis. Available at: http://www.who.int/immunization/ diseases/meningitis/en/. Accessed September 11, 2015.